Research News

Dr. Alejandro Villagra has received a new NIH R01 grant entitled "Development of selective HDAC6 inhibitors to improve cancer immunotherapy”, with a total funding amount of $3,024,000 for five years.

This research in Briefings in Bioinformatics identifies mutational hotspots in non-coding regions from multiple cancers through whole genome sequence analysis.

One H-1B nonimmigrant worker is being sought by The George Washington University through the filing of a labor condition application with the Employment and Training Administration of the U.S. Department of Labor.

HDAC6 plays a non-canonical role in the regulation of anti-tumor immune responses, dissemination, and invasiveness of breast cancer.

BGL3 lncRNA mediates retention of the BRCA1/BARD1 complex at DNA damage site.

This research, published in Cell Stem Cell defines how skin resident adipocytes contribute to macrophage inflammation after injury and change their cellular identity to become wound bed myofibroblasts.

Huadong Pei, PhD, assistant professor of biochemistry and molecular medicine at the George Washington University School of Medicine and Health Science, received funding from The Childhood Brain Tumor Foundation.